Colonial River Wealth Management, LLC Avrobio, Inc. Transaction History

Colonial River Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$1.22 - $1.62 $607 - $806	-498 Reduced 2.99%	16,177 $22,000
Q3 2023 Nov 03, 2023	SELL	$0.98 - $1.62 $259 - $429	-265 Reduced 1.56%	16,675 $25,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $1.11 $286 - $468	-422 Reduced 2.43%	16,940 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $205 - $364	-274 Reduced 1.55%	17,362 $16,000
Q1 2022 Apr 15, 2022	BUY	$1.29 - $4.04 $22,750 - $71,249	17,636 New	17,636 $23,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Colonial River Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Colonial River Wealth Management, LLC with notifications on news.